CU Startup News
OnKure, a privately-held biopharmaceutical company developing best-in-class, targeted oncology therapeutics, announced that it has raised $55 million in a Series B financing. Proceeds will be used to advance the Company’s next generation histone deacetylase (HDAC) inhibitors further into clinical development and fund a growing pipeline of earlier stage molecules.
Distinguished Engineering Professor Christopher Bowman, who is a serial inventor working with Venture Partners, has been elected to the National Academy of Engineering, one of the highest professional distinctions accorded to engineers. Bowman was chosen for his innovations related to photopolymerization, a process that uses light to trigger reactions that form new polymers. These polymers are used for an array of medical and technological applications, such as 3D printing, dental fillings, medical devices and augmented reality displays.
It’s hard to imagine a teenager who could resist exploring mechanical engineering after learning about Endoculus, the small device developed by CU Boulder Professor Mark Rentschler that can navigate the human gastrointestinal system with ease and may someday help doctors care for their patients. Futurum helped translate Rentschler’s complex research into easy-to-digest (no pun intended) content that teachers can incorporate into their lesson plans and share with their students.
The National Academy of Inventors (NAI) today announced that CU Boulder researchers and spinout founders Mark Rentschler, Greg Rieker and Tin Tin Su have been designated as NAI Senior Members in recognition of their impact on society through extraordinary innovation.
Arpeggio Bio is a therapeutics company that is developing cancer treatments. They share how they used their own technology to do drug discovery, and sold it as “consulting” to build credibility with investors and trust with a few initial clients.
In a statement, the Boulder company said the additional funds were part of a second close of its Series A round this year, bringing its total fundraising haul to the year to $214 million in both cash and non-cash funding. SomaLogic is developing blood-testing platforms to measure for thousands of proteins in a patient’s blood or urine sample that may signal current illnesses or risks for developing a future health condition.
CBSA celebrated companies and organizations driving new health innovations to save and change lives around the world during their 2020 virtual Annual Awards Celebration.
Their lead product, Onyx™ is based on tech exclusively licensed from CU Boulder.
Mechanical Engineering Professor Franck Vernerey, Assistant Mechanical Engineering Professor Carson Bruns and ATLAS Institute received $477,000 from the National Science Foundation to begin this three-year project in January 2021. Their research may one day enable soft machines to fully integrate with our bodies to deliver drugs, target tumors, or repair aging or dysfunctional tissue.
Led by professors Jianliang Xiao and Wei Zhang, researchers are developing a wearable electronic device that’s “really wearable”—a stretchy and fully-recyclable circuit board that’s inspired by, and sticks onto, human skin.